Suppr超能文献

表面引导定位消除了右侧乳腺癌放射治疗中皮肤标记的需要:一项单中心随机交叉试验。

Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: A single center randomized crossover trial.

机构信息

Department of Medical Physics, Oslo University Hospital, Oslo, Norway.

Department of Oncology, Oslo University Hospital, Oslo, Norway.

出版信息

Radiother Oncol. 2022 Dec;177:46-52. doi: 10.1016/j.radonc.2022.10.017. Epub 2022 Oct 26.

Abstract

BACKGROUND AND PURPOSE

To prospectively investigate whether surface guided setup of right sided breast cancer patients can increase efficiency and accuracy compared to traditional skin marker/tattoo based setup.

MATERIAL AND METHODS

Twenty-five patients were included in this study. Each patient was positioned using skin marks and tattoos (procedure A) for half of the fractions and surface guidance using AlignRT (procedure B) for the other half of the fractions. The order of the two procedures was randomized. Pretreatment CBCT was acquired at every fraction for both setup procedures. A total of ten time points were recorded during every treatment session. Applied couch shifts after CBCT match were recorded and used for potential error calculations if no CBCT had been used.

RESULTS

In the vertical direction procedure B showed significant smaller population based systematic (Ʃ) and random (σ) errors. However, a significant larger systematic error on the individual patient level (M) was also shown. This was found to be due to patient relaxation between setup and CBCT matching. Procedure B also showed a significant smaller random error in the lateral direction, while no significant differences were seen in the longitudinal direction. No significant difference in setup time was found between the two procedures.

CONCLUSION

Setup of right sided breast cancer patients using surface guidance yields higher accuracy than setup using skin marks/tattoos and lasers with the same setup time. Patient alignment for this patient group can safely be done without the use of permanent tattoos and skin marks when utilizing surface-guided patient positioning. However, CBCT should still be used as final setup verification.

摘要

背景与目的

本研究旨在前瞻性地评估与传统基于皮肤标记/纹身的摆位相比,表面引导摆位能否提高右侧乳腺癌患者的摆位效率和准确性。

材料与方法

本研究纳入了 25 例患者。每位患者的前一半分次治疗采用皮肤标记和纹身(A 程序)进行摆位,后一半分次治疗采用 AlignRT 表面引导(B 程序)进行摆位。两种程序的先后顺序随机确定。两种摆位程序的每一分次均行治疗前锥形束 CT(CBCT)扫描。每次治疗过程共记录 10 个时间点。记录 CBCT 配准后应用的治疗床位移动,并在未行 CBCT 扫描时用于潜在误差计算。

结果

在垂直方向,B 程序显示出显著较小的基于人群的系统(Ʃ)和随机(σ)误差。然而,个体患者水平上也显示出显著较大的系统误差(M)。这归因于患者在摆位和 CBCT 配准之间的放松。B 程序在侧方方向也显示出较小的随机误差,而在纵向方向则无显著差异。两种程序的摆位时间无显著差异。

结论

与使用皮肤标记/纹身和激光进行摆位相比,使用表面引导对右侧乳腺癌患者进行摆位可获得更高的准确性,且具有相同的摆位时间。对于此类患者群体,在使用表面引导患者定位时,可以安全地不使用永久性纹身和皮肤标记进行患者对准。但是,仍应使用 CBCT 作为最终摆位验证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验